Recombinant human erythropoietin therapy for autologous blood donation in rheumatoid arthritis patients undergoing total hip or knee arthroplasty

Orthopedics

Volumn 24, Issue 1, 2001, Pages 41-44

  Matsuda, S ^a   Kondo, M ^a   Mashima, T ^a   Hoshino, S ^a   Shinohara, N ^a   Sumida, S ^a  

^a KYUSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; C REACTIVE PROTEIN; CYANOCOBALAMIN; FOLIC ACID; HEMOGLOBIN; IRON; MANNITOL; PHOSPHATE; RECOMBINANT ERYTHROPOIETIN; RHEUMATOID FACTOR;

ADULT; AGED; ARTHROPLASTY; ARTICLE; BLOOD AUTOTRANSFUSION; BLOOD DONOR; BLOOD SAMPLING; BLOOD VOLUME; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; ORTHOPEDIC SURGERY; POSTOPERATIVE CARE; PREOPERATIVE CARE; PREOPERATIVE EVALUATION; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT;

AGED; ARTHRITIS, RHEUMATOID; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD TRANSFUSION, AUTOLOGOUS; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 0035142608     PISSN: 01477447     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Prior deposition of autologous blood in elective orthopedic surgery
2. Use of autologous blood in total hip replacement. A comprehensive program
3. Recombinant human erythropoietin in autologous blood donors: A dose-finding study
4. A phase III trial of recombinant human erythropoietin therapy in nonanemic orthopedic patients subjected to aggressive removal of blood for autologous use: Dose, response, toxicity, and efficacy
5. Increased preoperative collection of autologous blood with recombinant human erythropoietin therapy
6. The effect of patient size and dose of recombinant human erythropoietin therapy on red blood cell volume expansion in autologous blood donors for elective orthopedic operation
7. Recombinant human erythropoietin as adjuvant treatment for autologous blood donation
8. Subcutaneous administration of recombinant human erythropoietin before cardiac surgery: A double-blind, multicenter trial in Japan
9. Erythropoietin treatment to increase autologous blood donation in patients with low basal hematocrit undergoing elective orthopedic surgery
10. Effectiveness of very low doses of subcutaneous recombinant human erythropoietin in facilitating autologous blood donation before orthopedic surgery
11. Recombinant human erythropoietin for autologous blood donation: Effects on perioperative red-blood-cell and serum erythropoietin production
12. Treatment of the anemia of rheumatoid arthritis with recombinant human erythropoietin: Clinical and in vitro studies
13. Suppressed serum erythropoietin response to anemia and the efficacy of recombinant erythropoietin in the anemia of rheumatoid arthritis
14. Use of recombinant human erythropoietin to assist autologous blood donation by anemic rheumatoid arthritis patients undergoing major orthopedic surgery
15. Autologous blood transfusion with recombinant erythropoietin treatment. Twenty-two arthroplasties for rheumatoid arthritis